Astra Pulmicort Respules
Executive Summary
Asthma product designated "approvable" by FDA Feb. 11. The NDA (20-929) for the new dosage form of Pulmicort (budesonide) was submitted in November 1997. An advisory committee review of the product had been scheduled in April 1998, but was postponed